ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN was delisted on the 18th of July, 2024.
19 hedge funds and large institutions have $892K invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 5 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
14% less funds holding
Funds holding: 22 → 19 (-3)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
52% less capital invested
Capital invested by funds: $1.85M → $892K (-$959K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$14.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$9.33K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.28K |
| 4 |
Renaissance Technologies
New York
|
+$7.24K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4.85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$36.5K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$28K |
| 3 |
Walleye Capital
New York
|
-$11.3K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$10.2K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$6.27K |
ASLN Hedge Fund Activity: Q2 2024 in Review
19 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q2 2024, worth a combined $892K — down 52% from $1.85M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ASLN and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 7 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $14.3K. The largest seller was ADAR1 Capital Management, exiting entirely with an estimated $36.5K sold.
- 19 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q2 2024, down from 22 in Q1 2024.
- Funds reported $892K of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q2 2024, down 52% quarter-over-quarter.
- 3 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q2 2024 and 5 closed out, a net change of -2 holders.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q2 2024 was Two Sigma Securities, an estimated $14.3K added.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q2 2024 was ADAR1 Capital Management, an estimated $36.5K sold.
Based on aggregated 13F filings for Q2 2024.